Boston By The Numbers

The Boston drug discovery community is complex, multi-layered, and multi-player. This white paper examines the scientific and business trends across the community using data from Aspen Biosciences Pharm2Market platform.

What you’ll learn in the whitepaper:

  • What are the most prevalent therapeutic areas?

Learn more about the different therapeutic areas in the Boston community.

  • What therapeutic classes account for the largest/smallest percentage of current projects?

Learn what therapeutic classes are more prevalent in the Boston community.

  • How advanced are the biotech community pipelines?

Understand how mature the Boston biotech community is.

  • What are the recent funding developments & trends in the community?

Understand the current division of venture-funded, IPO stage, SBIR grants or partnerships in the Boston community.

  • What is the local presence of resource companies in the Boston area?

See the diverse array of resource companies providing materials and services that support the community.

  • Who are the investors in the Boston biotech community?

Learn what companies are the most active local and global investors in the area.

Download your Whitepaper

Scroll to Top